ANRO
Price
$11.35
Change
-$2.85 (-20.07%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
438.91M
Intraday BUY SELL Signals
BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANRO vs BEAM

Header iconANRO vs BEAM Comparison
Open Charts ANRO vs BEAMBanner chart's image
Alto Neuroscience
Price$11.35
Change-$2.85 (-20.07%)
Volume$7.18K
Capitalization438.91M
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$108.35K
Capitalization2.2B
ANRO vs BEAM Comparison Chart in %
View a ticker or compare two or three
VS
ANRO vs. BEAM commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ANRO: $14.20 vs. BEAM: $21.87)
Brand notoriety: ANRO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 22% vs. BEAM: 71%
Market capitalization -- ANRO: $350.82M vs. BEAM: $2.2B
ANRO [@Biotechnology] is valued at $350.82M. BEAM’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, ANRO is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ANRO is a better buy in the short-term than BEAM.

Price Growth

ANRO (@Biotechnology) experienced а +25.78% price change this week, while BEAM (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than ANRO($439M). ANRO YTD gains are higher at: 235.697 vs. BEAM (-11.815). ANRO has higher annual earnings (EBITDA): -62.3M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. ANRO (148M). ANRO has less debt than BEAM: ANRO (27.3M) vs BEAM (155M). BEAM has higher revenues than ANRO: BEAM (60.3M) vs ANRO (0).
ANROBEAMANRO / BEAM
Capitalization439M2.2B20%
EBITDA-62.3M-414.33M15%
Gain YTD235.697-11.815-1,995%
P/E RatioN/AN/A-
Revenue060.3M-
Total Cash148M1.15B13%
Total Debt27.3M155M18%
TECHNICAL ANALYSIS
Technical Analysis
ANROBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signal:
Gain/Loss:
BEAM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVIX11.330.06
+0.53%
American Century Focused Lg Cap Val Inv
MCBVX29.940.10
+0.34%
MFS Mid Cap Value B
PECAX15.710.02
+0.13%
JPMorgan SMID Cap Equity A
JOMMX16.03-0.01
-0.06%
JOHCM Emerging Mkts Discovery Instl
WBVRX29.54-0.02
-0.07%
William Blair Small Cap Value R6

ANRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANRO has been loosely correlated with BEAM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANRO jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+5.97%
BEAM - ANRO
37%
Loosely correlated
-2.71%
IMTX - ANRO
36%
Loosely correlated
+16.10%
CLYM - ANRO
35%
Loosely correlated
+1.05%
NUVL - ANRO
34%
Loosely correlated
+0.91%
ETHZ - ANRO
34%
Loosely correlated
+0.89%
More